J. B. Lecaillon

401 total citations
16 papers, 323 citations indexed

About

J. B. Lecaillon is a scholar working on Pharmacology, Small Animals and Infectious Diseases. According to data from OpenAlex, J. B. Lecaillon has authored 16 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Small Animals and 3 papers in Infectious Diseases. Recurrent topics in J. B. Lecaillon's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Helminth infection and control (5 papers) and Parasitic Diseases Research and Treatment (3 papers). J. B. Lecaillon is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Helminth infection and control (5 papers) and Parasitic Diseases Research and Treatment (3 papers). J. B. Lecaillon collaborates with scholars based in Switzerland, France and Italy. J. B. Lecaillon's co-authors include J. Godbillon, C. Souppart, M.C. Rouan, G. Kaiser, Maria Palmisano, Giovanni Della Cioppa, Joelle Campestrini, A.A. Poltera, J Cardot and César Náquira and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, American Heart Journal and British Journal of Clinical Pharmacology.

In The Last Decade

J. B. Lecaillon

15 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. B. Lecaillon Switzerland 8 112 71 62 49 47 16 323
Engy Shokry Germany 14 43 0.4× 52 0.7× 25 0.4× 35 0.7× 118 2.5× 38 486
Mia Parsonnet United States 7 197 1.8× 14 0.2× 22 0.4× 25 0.5× 54 1.1× 11 397
Chris J. van Boxtel Netherlands 12 24 0.2× 40 0.6× 29 0.5× 15 0.3× 33 0.7× 22 429
J. J. Aramayona Spain 17 299 2.7× 26 0.4× 38 0.6× 90 1.8× 41 0.9× 36 657
Jeff R. Wilcke United States 13 116 1.0× 26 0.4× 18 0.3× 10 0.2× 24 0.5× 29 370
M. Gips Israel 12 141 1.3× 6 0.1× 77 1.2× 14 0.3× 32 0.7× 17 468
A Mignot France 10 134 1.2× 16 0.2× 32 0.5× 46 0.9× 27 0.6× 27 328
U. Lamminsivu Finland 11 77 0.7× 31 0.4× 8 0.1× 17 0.3× 44 0.9× 19 343
Horst Beier Germany 10 110 1.0× 147 2.1× 86 1.4× 11 0.2× 36 0.8× 16 540
Eric Ormsby Canada 12 65 0.6× 35 0.5× 44 0.7× 24 0.5× 38 0.8× 18 341

Countries citing papers authored by J. B. Lecaillon

Since Specialization
Citations

This map shows the geographic impact of J. B. Lecaillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. B. Lecaillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. B. Lecaillon more than expected).

Fields of papers citing papers by J. B. Lecaillon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. B. Lecaillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. B. Lecaillon. The network helps show where J. B. Lecaillon may publish in the future.

Co-authorship network of co-authors of J. B. Lecaillon

This figure shows the co-authorship network connecting the top 25 collaborators of J. B. Lecaillon. A scholar is included among the top collaborators of J. B. Lecaillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. B. Lecaillon. J. B. Lecaillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lecaillon, J. B., et al.. (1999). Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder Inhalation via aerolizer TM. European Journal of Clinical Pharmacology. 55(2). 131–138. 75 indexed citations
2.
Lecaillon, J. B., J. Godbillon, Joelle Campestrini, et al.. (1998). Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. British Journal of Clinical Pharmacology. 45(6). 601–604. 43 indexed citations
3.
Cardot, J, et al.. (1998). The influence of food on the disposition of the antiepileptic rufinamide in healthy volunteers. Biopharmaceutics & Drug Disposition. 19(4). 259–262. 27 indexed citations
4.
Campestrini, Joelle, J. B. Lecaillon, & J. Godbillon. (1997). Automated and sensitive method for the determination of formoterol in human plasma by high-performance liquid chromatography and electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 704(1-2). 221–229. 25 indexed citations
5.
Godbillon, J., et al.. (1996). Bioequivalence assessment: a pharmaceutical industry perspective. European Journal of Drug Metabolism and Pharmacokinetics. 21(2). 153–158. 3 indexed citations
6.
Melange, Michel, et al.. (1992). Distomatose Des Voies Biliaires. Interet De La Cholangiography Retrograde. Efficacite Du Triclabendazole.. Acta Clinica Belgica. 47(3). 209–214. 4 indexed citations
7.
Lecaillon, J. B., et al.. (1991). Influence of food related to dose on the pharmacokinetics of amocarzine and of its N-oxide metabolite, CGP 13 231, after oral administration to 20 onchocerciasis male patients from Guatemala.. PubMed. 42(3). 286–90. 2 indexed citations
8.
Lecaillon, J. B., et al.. (1990). Pharmacokinetics of oxiracetam in elderly patients after 800 mg oral doses, comparison with non-geriatric healthy subjects. European Journal of Drug Metabolism and Pharmacokinetics. 15(3). 223–230. 7 indexed citations
9.
Lecaillon, J. B., et al.. (1990). The influence of food on the pharmacokinetics of CGP 6140 (amocarzine) after oral administration of a 1200 mg single dose to patients with onchocerciasis.. British Journal of Clinical Pharmacology. 30(4). 629–633. 7 indexed citations
10.
Lecaillon, J. B., et al.. (1990). Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral dose. European Journal of Drug Metabolism and Pharmacokinetics. 15(3). 231–237. 3 indexed citations
11.
Tantucci, Claudio, B Bruni, M Dottorini, et al.. (1990). Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: A double-blind, placebo-controlled crossover study. American Heart Journal. 120(2). 467–472. 12 indexed citations
12.
Lecaillon, J. B., et al.. (1990). Pharmacokinetics of CGP 6140 (amocarzine) after oral administration of single 100‐1600 mg doses to patients with onchocerciasis.. British Journal of Clinical Pharmacology. 30(4). 625–628. 5 indexed citations
13.
Brunel, Patrick, et al.. (1990). Influence of acetylator status on the haemodynamic effects and pharmacokinetics of cadralazine in healthy subjects.. British Journal of Clinical Pharmacology. 29(5). 503–509. 1 indexed citations
14.
Lecaillon, J. B., et al.. (1985). Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.. British Journal of Clinical Pharmacology. 19(S2). 245S–249S. 10 indexed citations
15.
Lecaillon, J. B., et al.. (1982). Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 228. 257–267. 86 indexed citations
16.
Lecaillon, J. B., et al.. (1980). Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans. Antimicrobial Agents and Chemotherapy. 18(5). 656–660. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Engy Shokry Breakdown of academic impact, for papers by Mia Parsonnet Breakdown of academic impact, for papers by Chris J. van Boxtel Breakdown of academic impact, for papers by J. J. Aramayona Breakdown of academic impact, for papers by Jeff R. Wilcke Breakdown of academic impact, for papers by M. Gips Breakdown of academic impact, for papers by A Mignot Breakdown of academic impact, for papers by U. Lamminsivu Breakdown of academic impact, for papers by Horst Beier Breakdown of academic impact, for papers by Eric Ormsby
Rankless by CCL
2026